Practice Management News

The American College of Rheumatology has submitted comments to CMS on proposed cuts to physician payments, warning of worsened burnout and staff shortages, and calling for “appropriate reimbursement,” according to a press release.

Professional fulfillment can be achieved through a culture of wellness, efficiency of practice in the workplace and personal resilience, according to a speaker at the Ending Clinician Burnout Global Summit.

The implementation of treat-to-target approaches for rheumatoid arthritis remains largely suboptimal, but could be improved with telehealth and other measures, according to data published in Arthritis Care & Research.

One important investment vehicle to understand when working toward slow and steady growth is the index fund.

A letter from the AMA's executive vice president called for CMS to be “fully transparent” on the impact that payment cuts in the 2025 Physician Fee Schedule will have on patients and physicians.

Biosimilar medications — drugs developed to be very similar, but not identical, to an FDA-approved biologic — were intended to play a vital role in increasing affordable options for patients struggling with a range of chronic conditions.

Chimeric antigen receptor T-cell therapy and precision medicine will highlight the agenda at the 40th annual Congress of Clinical Rheumatology West, set for Sept. 26 to Sept. 29 in San Diego, California.

Practicing shared decision-making increases overall trust in health care providers among patients with systemic lupus erythematosus, according to data published in Arthritis Care & Research.

The COVID-19 pandemic had a great impact on the health care system and the well-being of health care professionals, the effects of which are still felt today.

Nearly all biologic and targeted synthetic disease-modifying antirheumatic drugs come with infection or malignancy warnings from U.S. or European regulatory agencies, according to a study published in Drug Safety.